Find the Perfect Plan for Your Investment Journey
O
Latest price
52 Week Range
€0.07 - €2.00
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | €398.12K |
EV | €11.27M |
Shares Outstanding | 4.63M |
Beta | 0.86 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | -86.10% |
EPS | - |
Operating Cash Flow | 57.50% |
Free Cash Flow | 49.60% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | - |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
O
Oxurion NV
OXUR
Sector
Healthcare
Industry
Biotechnology
CEO
Ghoson, Pascal
Employees
11
Website
www.oxurion.comIPO Date
2006-07-07
Headquarters
Gaston Geenslaan 1, Leuven, Flemish Brabant, 3001, Belgium
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved